Barclays analyst Adrienne Yih upgraded Bath & Body Works to Overweight from Equal Weight with a price target of $45, up from $41. The analyst also upgraded the U.S. specialty appeal retail sector to Positive from Neutral. The firm is gaining confidence in a 2024 sector recovery, citing near-certain visibility on the inventory issue being largely resolved across the entirety of U.S. consumer discretionary goods by the end of 2023, with clean inventory setting the stage for a bottoming in merchandise margins in the second half of 2023 and margin improvement in 2024. In addition, freight and supply chain recapture is expected to improve materially beginning in the second half of 2023 with strengthening tailwinds in 2024, the analyst tells investors in a research note. Barclays also believes the wallet drag of “essential”-category inflation on discretionary goods within a household is abating.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BBWI:
- Bath & Body Works Appoints Eva C. Boratto as Chief Financial Officer
- Bath & Body Works appoints Eva Boratto as CFO
- Bath & Body Works call volume above normal and directionally bullish
- Bath & Body Works introduces new reformulated hand soap
- Bath & Body Works put volume heavy and directionally bearish